MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

198.07
-0.59
-0.30%
After Hours: 198.07 0 0.00% 16:00 04/09 EDT
OPEN
199.00
PREV CLOSE
198.66
HIGH
199.17
LOW
195.87
VOLUME
348.21K
TURNOVER
--
52 WEEK HIGH
223.62
52 WEEK LOW
145.11
MARKET CAP
10.46B
P/E (TTM)
31.82
1D
5D
1M
3M
1Y
5Y
5 Guru Stocks Predicted to Boost Earnings
GuruFocus News · 1d ago
Contract Research Organization Market Size 2025, Growth, Share, Industry Trends, Demand and Forecast to 2025
Japan, Japan, Thu, 08 Apr 2021 08:16:14 / Comserve Inc. / -- The report analyze market size, share, growth, trends, segmentation, top key players,...
Comserve · 2d ago
Contract Research Organization Services (CROs) Market (2020 to 2025) – Industry Trends, Share, Size, Growth, Opportunity and Forecast
Apr 08, 2021 (Heraldkeepers) -- The Contract Research Organization Services (CROs) Market is segmented on the lines of its type, end user and regional. Based...
Heraldkeepers · 3d ago
Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19
New York, April 08, Apr 08, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, April 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the...
GlobeNewswire · 3d ago
Bioanalytical Testing Services market is expected to grow at noteworthy CAGR around 7 % throughout the forecast period | ARC
Comserve · 3d ago
Healthcare Contract Research Outsourcing Market 2024 | Share, Growth Rate, Opportunities and Market Forecast
Apr 07, 2021 (AmericaNewsHour) -- Global Healthcare Contract Research Outsourcing Market is estimated to reach $58.9 billion by 2025; growing at a CAGR of...
AmericaNewsHour · 4d ago
Contract Research Organization Market Share, Growth, Statistics 2021-2026, By Size, Development, Trend, Key Manufacturers, Price, Supply Demand, Growth Factor, End User Analysis and Outlook
Apr 07, 2021 (The Expresswire) -- Global “Contract Research Organization Market” research report offers qualitative and quantitative insights in terms of...
The Express Wire · 4d ago
Artificial Vital Organs and Medical Bionics Market Covid 19 Impact Assessment, Current Growth Status, Major Key Players|Abbott Diabetes Care
Apr 07, 2021 (WiredRelease via Comtex) -- The studies on worldwide Artificial Vital Organs and Medical Bionics market evaluates the capabilities,...
marketresearch.biz · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ICLR. Analyze the recent business situations of ICON PLC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ICLR stock price target is 226.85 with a high estimate of 280.00 and a low estimate of 200.00.
EPS
Institutional Holdings
Institutions: 578
Institutional Holdings: 55.00M
% Owned: 104.19%
Shares Outstanding: 52.79M
TypeInstitutionsShares
Increased
124
1.78M
New
67
577.62K
Decreased
140
1.89M
Sold Out
29
145.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.53%
Pharmaceuticals & Medical Research
+0.26%
Key Executives
Non-Executive Chairman/Director
Ciaran Murray
Chief Executive Officer/Director
Steve Cutler
Chief Executive Officer/Director
Stephen Cutler
Chief Financial Officer/Executive Board/IR Contact Officer
Brendan Brennan
Executive Vice President/Chief Administrative Officer/General Counsel/Secretary
Diarmaid Cunningham
Lead Director/Independent Director
Ronan Murphy
Other
Kristen Buck
Independent Director
Hugh Brady
Independent Director
John Climax
Independent Director
Joan Garahy
Independent Director
William Hall
Independent Director
Eugene McCague
Independent Director
Julie O'Neill
Independent Director
Mary Pendergast
No Data
About ICLR
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Webull offers kinds of ICON PLC stock information, including NASDAQ:ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.